The metabolic syndrome is a cluster of metabolic complications—including atherogenic dyslipidemia, insulin resistance, glucose intolerance, raised blood pressure, and a prothrombotic and inflammatory state—that are more often found in patients with abdominal obesity (19). As a common metabolic disorder, the metabolic syndrome is directly linked to obesity, abdominal obesity in particular (19). Because of the syndrome’s ties to obesity, the number of individuals with the metabolic syndrome has risen in step with the worldwide obesity and diabetes epidemic (20). This rise in obesity has facilitated recognition of the syndrome and, consequently, the importance of abdominal obesity as a key contributor to the metabolic syndrome. The recent inclusion of waist circumference as a clinical criterion for diagnosing the metabolic syndrome (21) cements the key role played by abdominal obesity in the metabolic syndrome (22). Therefore, in addition to overweight and obesity—both established risk factors for the metabolic syndrome—patterns of body fat distribution (i.e., abdominal obesity) may increase risk for this diabetogenic and atherogenic condition (23).

Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD
More
What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD
More
Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91
More
Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease
More